U.S. Markets closed

Moody's: European pharma sector earnings poised to rise into 2019 as new drugs come to market

An emerging wave of blockbuster drugs will accelerate European pharmaceutical companies' revenue growth into 2019, says Moody's Investors Service in a report published today. The rating agency's report is an update to the markets and does not constitute a rating action.